TNFAIP3 expression and microglia polarization at different time points in the MCAO/R model. by Wenya Bai (13236381)

Non-metric multidimensional scaling (NMDS) plots of endophytic bacterial communities at OTUs level calculated with the method of Bray Curtis according to the plant tissue (A), phen... by Rabiath F. R. Adigoun (14189090)

Network analysis of perceived first-order trade-offs and synergies before the political process in Savognin (A) and Sedrun (B), and after the political process in Savognin (C) and... by Javier Feller Valero (22821605)

General procedure for the synthesis of B. by Xueqin lu (22250795)

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”

¹H NMR spectra for kylo-0603. by Xueqin lu (22250795)

“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”

The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”

Synthesis process of Kylo-0603. by Xueqin lu (22250795)

“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”

ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

Correlation between near-source wastewater SARS-CoV-2 detections and national surveillance, using individual daily data points (top row) and a five-day moving average (bottom row). by Jay C. Bullen (10232606)

Computational Fluid Dynamics results for a parallel plate flow chamber based on FLUENT. by Xinyao Zhao (5824427)

Frost heave rate of different collection points of the sample. by Haotian Guo (6620120)

Image 1_Chromosome 1 variants associated with decreased HIV set-point viral load correlate with PRKAB2 expression changes.png by Riley H. Tough (14432838)